Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1985 1
1986 6
1987 4
1988 3
1989 6
1990 6
1991 3
1992 3
1993 2
1994 1
1995 5
1996 6
1997 5
1998 12
1999 12
2000 11
2001 7
2002 4
2003 4
2004 4
2005 5
2006 6
2007 11
2008 5
2009 8
2010 11
2011 10
2012 10
2013 10
2014 6
2015 18
2016 8
2017 9
2018 6
2019 5
2020 3
2021 11
2022 6
2023 2

Text availability

Article attribute

Article type

Publication date

Search Results

231 results

Results by year

Filters applied: . Clear all
Page 1
Alpha-synuclein in Lewy bodies.
Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Spillantini MG, et al. Nature. 1997 Aug 28;388(6645):839-40. doi: 10.1038/42166. Nature. 1997. PMID: 9278044 No abstract available.
Age-dependent formation of TMEM106B amyloid filaments in human brains.
Schweighauser M, Arseni D, Bacioglu M, Huang M, Lövestam S, Shi Y, Yang Y, Zhang W, Kotecha A, Garringer HJ, Vidal R, Hallinan GI, Newell KL, Tarutani A, Murayama S, Miyazaki M, Saito Y, Yoshida M, Hasegawa K, Lashley T, Revesz T, Kovacs GG, van Swieten J, Takao M, Hasegawa M, Ghetti B, Spillantini MG, Ryskeldi-Falcon B, Murzin AG, Goedert M, Scheres SHW. Schweighauser M, et al. Among authors: spillantini mg. Nature. 2022 May;605(7909):310-314. doi: 10.1038/s41586-022-04650-z. Epub 2022 Mar 28. Nature. 2022. PMID: 35344985 Free PMC article.
Frontotemporal dementia and its subtypes: a genome-wide association study.
Ferrari R, Hernandez DG, Nalls MA, Rohrer JD, Ramasamy A, Kwok JB, Dobson-Stone C, Brooks WS, Schofield PR, Halliday GM, Hodges JR, Piguet O, Bartley L, Thompson E, Haan E, Hernández I, Ruiz A, Boada M, Borroni B, Padovani A, Cruchaga C, Cairns NJ, Benussi L, Binetti G, Ghidoni R, Forloni G, Galimberti D, Fenoglio C, Serpente M, Scarpini E, Clarimón J, Lleó A, Blesa R, Waldö ML, Nilsson K, Nilsson C, Mackenzie IR, Hsiung GY, Mann DM, Grafman J, Morris CM, Attems J, Griffiths TD, McKeith IG, Thomas AJ, Pietrini P, Huey ED, Wassermann EM, Baborie A, Jaros E, Tierney MC, Pastor P, Razquin C, Ortega-Cubero S, Alonso E, Perneczky R, Diehl-Schmid J, Alexopoulos P, Kurz A, Rainero I, Rubino E, Pinessi L, Rogaeva E, St George-Hyslop P, Rossi G, Tagliavini F, Giaccone G, Rowe JB, Schlachetzki JC, Uphill J, Collinge J, Mead S, Danek A, Van Deerlin VM, Grossman M, Trojanowski JQ, van der Zee J, Deschamps W, Van Langenhove T, Cruts M, Van Broeckhoven C, Cappa SF, Le Ber I, Hannequin D, Golfier V, Vercelletto M, Brice A, Nacmias B, Sorbi S, Bagnoli S, Piaceri I, Nielsen JE, Hjermind LE, Riemenschneider M, Mayhaus M, Ibach B, Gasparoni G, Pichler S, Gu W, Rossor MN, Fox NC, Warren JD, Spilla… See abstract for full author list ➔ Ferrari R, et al. Among authors: spillantini mg. Lancet Neurol. 2014 Jul;13(7):686-99. doi: 10.1016/S1474-4422(14)70065-1. Lancet Neurol. 2014. PMID: 24943344 Free PMC article.
Synucleinopathies: past, present and future.
Spillantini MG, Goedert M. Spillantini MG, et al. Neuropathol Appl Neurobiol. 2016 Feb;42(1):3-5. doi: 10.1111/nan.12311. Neuropathol Appl Neurobiol. 2016. PMID: 26819143 No abstract available.
Editorial: Tau Pathology in Neurological Disorders.
Do Carmo S, Spillantini MG, Cuello AC. Do Carmo S, et al. Among authors: spillantini mg. Front Neurol. 2021 Sep 24;12:754669. doi: 10.3389/fneur.2021.754669. eCollection 2021. Front Neurol. 2021. PMID: 34630315 Free PMC article. No abstract available.
Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind, placebo-controlled phase 1a trial.
Levin J, Sing N, Melbourne S, Morgan A, Mariner C, Spillantini MG, Wegrzynowicz M, Dalley JW, Langer S, Ryazanov S, Leonov A, Griesinger C, Schmidt F, Weckbecker D, Prager K, Matthias T, Giese A. Levin J, et al. Among authors: spillantini mg. EBioMedicine. 2022 Jun;80:104021. doi: 10.1016/j.ebiom.2022.104021. Epub 2022 Apr 29. EBioMedicine. 2022. PMID: 35500536 Free PMC article. Clinical Trial.
Propagation of Tau aggregates.
Goedert M, Spillantini MG. Goedert M, et al. Among authors: spillantini mg. Mol Brain. 2017 May 30;10(1):18. doi: 10.1186/s13041-017-0298-7. Mol Brain. 2017. PMID: 28558799 Free PMC article. Review.
Non-Alzheimer degenerative dementias.
Lowe J, Spillantini MG. Lowe J, et al. Among authors: spillantini mg. Brain Pathol. 1998 Apr;8(2):295-7. doi: 10.1111/j.1750-3639.1998.tb00155.x. Brain Pathol. 1998. PMID: 9546288 Free PMC article. Review. No abstract available.
The Synucleinopathies: Twenty Years On.
Goedert M, Jakes R, Spillantini MG. Goedert M, et al. Among authors: spillantini mg. J Parkinsons Dis. 2017;7(s1):S51-S69. doi: 10.3233/JPD-179005. J Parkinsons Dis. 2017. PMID: 28282814 Free PMC article. Review.
231 results